Discussing the results, R Chandrasekaran, executive vice chairman, Cognizant India, said the company has been “feeling good about the demand environment†and has been winning significant number of deals.
US healthcare clients are desperate to cut costs and therefore, there cannot be a better time than today to buy TriZetto, says Gordon Coburn, President, Cognizant.
The acquisition will position Cognizant to address the rapidly changing healthcare marketplace that currently holds 17 percent of the US GDP.